发明名称 |
The combination of a serotonin reuptake inhibitor and irindalone |
摘要 |
The present invention relates to the use of compounds and compositions of compounds having serotonin reuptake inhibiting activity and 5-HT 2C antagonistic, partial agonistic or inverse agonistic activity for the for the treatment of depression and other affective disorders. The combined serotonin reuptake inhibiting effect and the 5-HT 2C antagonistic, partial agonistic or inverse agonistic effect may reside within the same chemical compound or in two different chemical compounds. |
申请公布号 |
AU1850801(A) |
申请公布日期 |
2001.06.18 |
申请号 |
AU20010018508 |
申请日期 |
2000.12.04 |
申请人 |
H. LUNDBECK, A/S |
发明人 |
KLAUS PETER BOGESO;THOMAS IVO FRANCISCUS HUBERT CREMERS |
分类号 |
A61K;A61K31/00;A61K31/135;A61K31/137;A61K31/138;A61K31/15;A61K31/343;A61K31/405;A61K31/4439;A61K31/445;A61K31/4525;A61K31/496;A61K31/497;A61K31/513;A61K31/519;A61K31/55;A61K31/551;A61K33/36;A61K45/06;A61P1/14;A61P3/04;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P43/00;G01N33/94 |
主分类号 |
A61K |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|